Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Congress 2021 - 1000x250

Friday 17 September

Homologous Recombination Deficiency: BRCA and Beyond

02-Homologous-Recombination-Deficiency-BRCA-and-Beyond-MSD-Thumb

Friday, 08:45 - 09:50
View the satellite invitation

From Breast Cancer Biology to Therapy

04-Redefining-Breast-Cancer-Biology-to-Therapy-ASTRAZENECA-Thumb

Friday, 08:45 - 10:15
View the satellite invitation

The Role of Biomarkers in Patient Management in Immuno-Oncology

06-The-Role-of-Biomarkers-in-Patient-Management-in-Immuno-Oncology-MSD-Thumb

Friday, 10:30 - 11:30
View the satellite invitation

Saturday 18 September

Confidence and Clarity in Advanced Breast Cancer: Insights From The Real World

17-Confidence-and-Clarity-in-Advanced-Breast-Cancer-Insights-From-the-Real-World-PFIZER-Thumb

Saturday, 10:30 - 12:00
View the satellite invitation

Navigating a New Era in HER2+ Metastatic Breast Cancer: Focus on HER2CLIMB

19-Navigating-a-New-Era-in-HER2-Metastatic-Breast-Cancer-Focus-on-HER2CLIMB-SEAGEN-Thumb

Saturday, 10:30 - 12:00
View the satellite invitation

Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies

21-Advances-in-Antibody-Drug-Conjugates-in-Solid-Tumors-Current-Treatments-and-Emerging-Therapies-DAIICHI-Thumb

Saturday, 18:45 - 20:15
View the satellite invitation

Sunday 19 September

Improving Survival Outcomes in HR+/HER2− Advanced Breast Cancer: A Biological Perspective

29-Improving-Survival-Outcomes-in-HR-HER2-Advanced-Breast-Cancer-A-Biological-Perspective-NOVARTIS-Thumb

Sunday, 10:30 - 12:00
View the satellite invitation

Monday 20 September

Developments in Precision Medicine for Breast and Ovarian Cancers

39-Developments-in-Precision-Medicine-for-Breast-and-Ovarian-Cancers-MYRIAD-Thumb

Monday, 08:45 - 10:15
View the satellite invitation

Triple-Negative Breast Cancer: See Beyond the Negatives 

48-Triple-Negative-Breast-Cancer-See-Beyond-the-Negatives-GILEAD-Thumb

Monday, 18:45 - 20:15
View the satellite invitation

Tuesday 21 September

Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors

53-Leveraging-Antibody-Drug-Conjugates-in-Cancer-Care-Evolving-Approaches-to-Bridge-Clinical-Gaps-in-Breast-GI-and-Lung-Tumors-PER-Thumb

Tuesday, 10:30 - 12:00
View the satellite invitation

Emerging Agents in Breast Cancer Care

58-Leading-New-Standards-in-Breast-Cancer-Care-ASTRAZENECA-Thumb

Tuesday, 17:35 - 19:05
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.